This assay is designed for the detection of anti-CCP3 IgG and IgA antibodies in patient sera, citrated or EDTA plasma. The presence of these antibodies can aid in the diagnosis of rheumatoid arthritis (RA), including RA diagnosed within 2 years of presentation of symptoms.

IVD-In Vitro Diagnostic Use / CE marked

Technology
ELISA

CLIA complexity
High

Package Size
1 X 96 wells

Disease Area Application
Rheumatoid Arthritis (RA)

Antigen Source
Synthetic peptide

Contact Us

Contact us directly using the below, or by filling out the form.

Tel: 01925 810 141 - Option 6

 

Tel: 0800 102 6342

 

Tel: 01925 810 141 - Option 1

DATA PROCESSING NOTICE:

Werfen Ltd will process your personal data to respond to your requests for information or support, or to understand your needs and provide you with a better service relying on our legitimate interest to do so. You can find more information about our data privacy practices and how to exercise your rights in our Privacy Policy. You can also contact us at DPO-uk@werfen.com.